Interspecies scaling in pharmacokinetics: a novel whole-body physiologically based modeling framework to discover drug biodistribution mechanisms in vivo
C Hall, E Lueshen, AA Linninger - Journal of pharmaceutical sciences, 2012 - Elsevier
Drug approval processes require extensive testing and have recently put more emphasis on
understanding mechanistic drug action in the body including toxicity and safety. 1 …
understanding mechanistic drug action in the body including toxicity and safety. 1 …
Interspecies scaling in pharmacokinetics: A novel whole‐body physiologically based modeling framework to discover drug biodistribution mechanisms in vivo
C Hall, E Lueshen, AA Linninger - Journal of Pharmaceutical Sciences, 2012 - infona.pl
Drug approval processes require extensive testing and have recently put more emphasis on
understanding mechanistic drug action in the body including toxicity and safety. 1 …
understanding mechanistic drug action in the body including toxicity and safety. 1 …
Interspecies scaling in pharmacokinetics: a novel whole-body physiologically based modeling framework to discover drug biodistribution mechanisms in vivo.
C Hall, E Lueshen, A Mošat… - Journal of Pharmaceutical …, 2011 - europepmc.org
Drug approval processes require extensive testing and have recently put more emphasis on
understanding mechanistic drug action in the body including toxicity and safety. 1 …
understanding mechanistic drug action in the body including toxicity and safety. 1 …
[引用][C] Interspecies Scaling in Pharmacokinetics: A Novel Whole-Body Physiologically Based Modeling Framework to Discover Drug Biodistribution Mechanisms In …
C HALL, E LUESHEN, A MOSAT… - Journal of …, 2012 - pascal-francis.inist.fr
Interspecies Scaling in Pharmacokinetics: A Novel Whole-Body Physiologically Based Modeling
Framework to Discover Drug Biodistribution Mechanisms In Vivo CNRS Inist Pascal-Francis …
Framework to Discover Drug Biodistribution Mechanisms In Vivo CNRS Inist Pascal-Francis …
Interspecies scaling in pharmacokinetics: A novel whole‐body physiologically based modeling framework to discover drug biodistribution mechanisms in vivo
C Hall, E Lueshen, A Mošat'… - Journal of …, 2012 - Wiley Online Library
Drug approval processes require extensive testing and have recently put more emphasis on
understanding mechanistic drug action in the body including toxicity and safety. 1 …
understanding mechanistic drug action in the body including toxicity and safety. 1 …
Interspecies Scaling in Pharmacokinetics: A Novel Whole-Body Physiologically Based Modeling Framework to Discover Drug Biodistribution Mechanisms in vivo
C Hall, E Lueshen, AA Linninger - Journal of Pharmaceutical …, 2012 - jpharmsci.org
Drug approval processes require extensive testing and have recently put more emphasis on
understanding mechanistic drug action in the body including toxicity and safety. 1 …
understanding mechanistic drug action in the body including toxicity and safety. 1 …
[引用][C] Interspecies Scaling in Pharmacokinetics: A Novel Whole-Body Physiologically Based Modeling Framework to Discover Drug Biodistribution Mechanisms in …
C Hall, E Lueshen, AAL Andrej Mošat - Journal of Pharmaceutical …, 2012 - cir.nii.ac.jp
Interspecies Scaling in Pharmacokinetics: A Novel Whole-Body Physiologically Based Modeling
Framework to Discover Drug Biodistribution Mechanisms in vivo | CiNii Research CiNii 国立 …
Framework to Discover Drug Biodistribution Mechanisms in vivo | CiNii Research CiNii 国立 …
Interspecies scaling in pharmacokinetics: a novel whole-body physiologically based modeling framework to discover drug biodistribution mechanisms in vivo
C Hall, E Lueshen… - Journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Drug approval processes require extensive testing and have recently put more emphasis on
understanding mechanistic drug action in the body including toxicity and safety. 1 …
understanding mechanistic drug action in the body including toxicity and safety. 1 …